Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

M-Rabet, M. ; Cabaud, O. ; Josselin, E. ; Finetti, P. ; Castellano, R. ; Farina, A. ; Agavnian-Couquiaud, E. ; Saviane, G. ; Collette, Y. ; Viens, P. ; Gonçalves, A. ; Ginestier, C. ; Charafe-Jauffret, E. ; Birnbaum, D. ; Olive, D. ; Bertucci, F. ; Lopez, M.

England: Elsevier Ltd

Texto completo disponível

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

Bonnefoi, H. ; Grellety, T. ; Tredan, O. ; Saghatchian, M. ; Dalenc, F. ; Mailliez, A. ; L'Haridon, T. ; Cottu, P. ; Abadie-Lacourtoisie, S. ; You, B. ; Mousseau, M. ; Dauba, J. ; Del Piano, F. ; Desmoulins, I. ; Coussy, F. ; Madranges, N. ; Grenier, J. ; Bidard, F.C. ; Proudhon, C. ; MacGrogan, G. ; Orsini, C. ; Pulido, M. ; Gonçalves, A.

England: Elsevier Ltd

Texto completo disponível

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Belin, L. ; Kamal, M. ; Mauborgne, C. ; Plancher, C. ; Mulot, F. ; Delord, J.-P. ; Gonçalves, A. ; Gavoille, C. ; Dubot, C. ; Isambert, N. ; Campone, M. ; Trédan, O. ; Ricci, F. ; Alt, M. ; Loirat, D. ; Sablin, M.-P. ; Paoletti, X. ; Servois, V. ; Le Tourneau, C.

England: Elsevier Ltd

Texto completo disponível

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling

Gonçalves-Ribeiro, S. ; Sanz-Pamplona, R. ; Vidal, A. ; Sanjuan, X. ; Guillen Díaz-Maroto, N. ; Soriano, A. ; Guardiola, J. ; Albert, N. ; Martínez-Villacampa, M. ; López, I. ; Santos, C. ; Serra-Musach, J. ; Salazar, R. ; Capellà, G. ; Villanueva, A. ; Molleví, D.G.

England: Elsevier Ltd

Texto completo disponível

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

Pierga, J.-Y. ; Bidard, F.-C. ; Cropet, C. ; Tresca, P. ; Dalenc, F. ; Romieu, G. ; Campone, M. ; Mahier Aït-Oukhatar, C. ; Le Rhun, E. ; Gonçalves, A. ; Leheurteur, M. ; Dômont, J. ; Gutierrez, M. ; Curé, H. ; Ferrero, J.-M. ; Labbe-Devilliers, C. ; Bachelot, T.

Oxford: Elsevier Ltd

Texto completo disponível

START: A randomized phase II study in patients with triple negative, androgen receptor positive locally recurrent (unresectable) or metastatic breast cancer treated with darolutamide or capecitabine (UCBG-306)

Bonnefoi, H. ; Levy, C. ; MacGrogan, G. ; Grellety, T. ; Asselain, B. ; Pulido, M. ; Everhard, S. ; Lemonnier, J. ; Gonçalves, A.

England: Elsevier Ltd

Texto completo disponível

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study

Delaloge, S. ; Wolp-Diniz, R. ; Byrski, T. ; Blum, J.L. ; Gonçalves, A. ; Campone, M. ; Lardelli, P. ; Kahatt, C. ; Nieto, A. ; Cullell-Young, M. ; Lubinski, J.

Oxford: Elsevier Ltd

Texto completo disponível

312TiP Impact of early palliative care integration on quality of life and symptom burden in patients with high-grade glioma

Reis, J.S. ; Nogueira Costa, I.C. ; Caeiro, C.L.B. ; Costa, A.S.A. ; Fernandes, A.C. ; Gonçalves, E. ; Tavares, T. ; Moreira, C. ; Barbosa, M. ; Valente, A.C. ; Costa, M.J.

Texto completo disponível

58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment

Marmé, F. ; Hanusch, C. ; Furlanetto, J. ; Morris, P. ; Link, T. ; Denkert, C. ; Fasching, P.A. ; Jackisch, C. ; Antolín, S. ; Solbach, C. ; Aftimos, P. ; Huober, J. ; Untch, M. ; Balic, M. ; Reinisch, M. ; Blohmer, J-U. ; Gonçalves, A. ; Rey, J. ; Büchele, T. ; Loibl, S.

Elsevier Ltd

Texto completo disponível

1629O_PR - The price of added value for new anti-cancer drugs in France 2004-17

Marino, P. ; Jalbert, A.-C. ; Duran, S. ; Mancini, J. ; Gonçalves, A. ; Rodwin, M.

Elsevier Ltd

Texto completo disponível